Real-world economic impact of onabotulinumtoxina in patients with chronic migraine

被引：0
|
作者：
Rothrock, J. F. [1 ]
Bloudek, L. M. [2 ]
Houle, T. T. [3 ]
Andress-Rothrock, D. [4 ]
Hanlon, C. [1 ]
Varon, S. F. [2 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[4] Univ Alabama Birmingham, Headache Treatment & Res Program, Birmingham, AL USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2013年 / 14卷
关键词：
Migraine; Chronic Migraine; Episodic Migraine; onabotulinumtoxinA; Urgent Care Center;
D O I：
10.1186/1129-2377-14-S1-P216
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Hyoung Cheol Lee
    Soohyun Cho
    Byung-Kun Kim
    Neurological Sciences, 2023, 44 : 2455 - 2463
  • [42] Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study
    Manack Adams, Aubrey
    Hutchinson, Susan
    Engstrom, Ella
    Ayasse, Nicolai D.
    Serrano, Daniel
    Davis, Linda
    Sommer, Katherine
    Contreras-De Lama, Janette
    Lipton, Richard B.
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
  • [43] Real-world effectiveness of erenumab in Japanese patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Shiina, Tomohiko
    Haruyama, Yasuo
    Kobayashi, Saro
    Shioda, Mukuto
    Hirata, Koichi
    HELIYON, 2024, 10 (04)
  • [44] Wearing Off Response to OnabotulinumtoxinA in Chronic Migraine: Analysis in a Series of 193 Patients
    Quintas, Sonia
    Garcia-Azorin, David
    Heredia, Patricia
    Talavera, Blanca
    Beatriz Gago-Veiga, Ana
    Guerrero, Angel L.
    PAIN MEDICINE, 2019, 20 (09) : 1815 - 1821
  • [45] OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study
    Altamura, Claudia
    Ornello, R.
    Ahmed, F.
    Negro, A.
    Miscio, A. M.
    Santoro, A.
    Alpuente, A.
    Russo, A.
    Silvestro, M.
    Cevoli, S.
    Brunelli, N.
    Grazzi, L.
    Baraldi, C.
    Guerzoni, S.
    Andreou, A. P.
    Lambru, G.
    Frattale, I
    Kamm, K.
    Ruscheweyh, R.
    Russo, M.
    Torelli, P.
    Filatova, E.
    Latysheva, N.
    Gryglas-Dworak, A.
    Straburzynski, M.
    Butera, C.
    Colombo, B.
    Filippi, M.
    Pozo-Rosich, P.
    Martelletti, P.
    Sacco, S.
    Vernieri, F.
    JOURNAL OF NEUROLOGY, 2023, 270 (02) : 986 - 994
  • [46] Effects of OnabotulinumtoxinA on Allodynia and Interictal Burden of Patients with Chronic Migraine
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Rikos, Dimitrios
    Xiromerisiou, Georgia
    Soldatos, Panagiotis
    Litsardopoulos, Pantelis
    Vikelis, Michail
    TOXINS, 2024, 16 (02)
  • [47] OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
    Sastre Real, Maria
    Diaz de Teran, Javier
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [48] OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study
    Claudia Altamura
    R. Ornello
    F. Ahmed
    A. Negro
    A. M. Miscio
    A. Santoro
    A. Alpuente
    A. Russo
    M. Silvestro
    S. Cevoli
    N. Brunelli
    L. Grazzi
    C. Baraldi
    S. Guerzoni
    A. P. Andreou
    G. Lambru
    I. Frattale
    K. Kamm
    R. Ruscheweyh
    M. Russo
    P. Torelli
    E. Filatova
    N. Latysheva
    A. Gryglas-Dworak
    M. Straburzynski
    C. Butera
    B. Colombo
    M. Filippi
    P. Pozo-Rosich
    P. Martelletti
    S. Sacco
    F. Vernieri
    Journal of Neurology, 2023, 270 : 986 - 994
  • [49] Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment – real world outcomes
    J. Talbot
    R. Stuckey
    L. Crawford
    S. Weatherby
    S. Mullin
    The Journal of Headache and Pain, 2021, 22
  • [50] Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
    Ornello, Raffaele
    Ahmed, Fayyaz
    Negro, Andrea
    Miscio, Anna Maria
    Santoro, Antonio
    Alpuente, Alicia
    Russo, Antonio
    Silvestro, Marcello
    Cevoli, Sabina
    Brunelli, Nicoletta
    Vernieri, Fabrizio
    Grazzi, Licia
    Baraldi, Carlo
    Guerzoni, Simona
    Andreou, Anna P.
    Lambru, Giorgio
    Kamm, Katharina
    Ruscheweyh, Ruth
    Russo, Marco
    Torelli, Paola
    Filatova, Elena
    Latysheva, Nina
    Gryglas-Dworak, Anna
    Straburzynski, Marcin
    Butera, Calogera
    Colombo, Bruno
    Filippi, Massimo
    Pozo-Rosich, Patricia
    Martelletti, Paolo
    Sacco, Simona
    PAIN AND THERAPY, 2021, 10 (02) : 1605 - 1618
12345